Streetbeat News

Stock Prices

BBIO

Analysts have provided bullish ratings for BridgeBio Pharma (NASDAQ:BBIO) in the last quarter. In the last 3 months, 4 analysts have offered 12-month price targets for BridgeBio Pharma with an average price target of $52.0, an increase of 13.04% from the previous average price target of $46.00.

Portfolio Pulse from Benzinga Insights

October 24, 2023 | 12:01 pm

BTCUSD

QQQ

UBER

XLP

On CNBC's 'Halftime Report Final Trades', Liz Young of BNY Mellon Investment Management recommended Consumer Staples Select Sector SPDR Fund (XLP), Joseph Terranova of Virtus Investment Partners picked Uber Technologies (UBER), Anastasia Amoroso is buying shares of Invesco QQQ Trust (QQQ), and Stephen Weiss of Short Hills Capital Partners named Bitcoin (BTC) as his final trade. Uber is set to report its Q3 financial results on Nov. 7, 2023. Invesco QQQ Trust and Uber shares rose, while XLP fell.

Portfolio Pulse from Lisa Levin

October 24, 2023 | 12:01 pm

CUBE

In the last quarter, CubeSmart (NYSE:CUBE) received 1 bullish, 2 somewhat bullish, and 3 indifferent analyst ratings. Over the past 3 months, 6 analysts have offered 12-month price targets for CubeSmart, with an average price target of $45.5, a decrease of 7.61% from the previous average price target of $49.25.

Portfolio Pulse from Benzinga Insights

October 24, 2023 | 12:01 pm

ASO

Academy Sports (NASDAQ:ASO) has received mostly bullish ratings from analysts in the last quarter, with an average price target of $65.73, up 3.68% from the previous average of $63.40. The ratings are based on predictions of the company's future earnings and revenue streams.

Portfolio Pulse from Benzinga Insights

October 24, 2023 | 12:00 pm

CABA

Over the last quarter, Cabaletta Bio (NASDAQ:CABA) has received 7 bullish analyst ratings, with an average 12-month price target of $28.57, a significant increase from the previous average of $14.50. No bearish or indifferent ratings were observed.

Portfolio Pulse from Benzinga Insights

October 24, 2023 | 12:00 pm

IR

Ingersoll Rand (NYSE:IR) has received mostly bullish ratings from analysts in the last quarter, with 2 bullish and 3 somewhat bullish ratings. The average 12-month price target for the company has increased by 6.97% from the previous average, now standing at $73.17.

Portfolio Pulse from Benzinga Insights

October 24, 2023 | 12:00 pm

BTCUSD

GBTC

Peter Schiff, a gold investor, has warned that the current Bitcoin rally could peak if the Grayscale Bitcoin Trust (GBTC) is approved to convert into an ETF by the SEC. He suggests that a potential selloff could occur if this conversion takes place. This comes as the SEC and Grayscale's dispute over the approval of a spot bitcoin ETF has concluded, with the D.C. Circuit Court of Appeals directing the SEC to abandon its rejection of Grayscale's application.

Portfolio Pulse from Mehab Qureshi

October 24, 2023 | 12:00 pm

GE

GE's CEO has stated that the company's offshore wind sector will continue to experience similar losses in 2024 as in 2023, but cash flow will improve. The offshore wind sector is expected to incur losses of approximately $1B in 2023.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 11:57 am

GE

GE's CFO has stated that demand remains robust at GE Aerospace, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 11:56 am

APRN

EXTO

Blue Apron Holdings, Inc. (APRN) and Almacenes Éxito S.A. (EXTO) are considered overbought stocks in the consumer staples sector, with RSI values of 76.88 and 72.67 respectively. Blue Apron is set to be acquired by Wonder Group for $13 per share, while Almacenes Éxito's stock has jumped more than 25% over the past month.

Portfolio Pulse from Lisa Levin

October 24, 2023 | 11:54 am